Page 1

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 10 - K ANNUAL REPORT UNDER SECTION 13 OR 15 ( D ) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31 , 2020 TRANSITION REPORT UNDER SECTION 13 OR 15 ( D ) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ΤΟ BRAINSTORM CELL THERAPEUTICS INC . ( Exact Name of Registrant as specified in its charter ) Delaware ( State or other jurisdiction of incorporation or organization ) COMMISSION FILE NUMBER 001-36641 1325 Avenue of Americas , 28th Floor New York , NY ( Address of principal executive offices ) Title of each class Common Stock , $ 0.00005 par value 20-7273918 ( I.R.S. Employer Identification No. ) Registrant's telephone number , including area code : ( 201 ) 488-0460 Securities registered under Section 12 ( b ) of the Act : Trading Symbol ( s ) BCLI 10019 ( Zip Code ) Name of each exchange on which registered The Nasdaq Stock Market LLC ( Nasdaq Capital Market ) Securities registered under Section 12 ( g ) of the Act : None Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No " Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15 ( d ) of the Act . Yes No Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes No¨ Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer , " " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . ( Check one ) : Large accelerated filer Non - accelerated filer Accelerated filer Smaller reporting company Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report ,. Yes No No = Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes The approximate aggregate market value of the voting and non - voting common equity held by non - affiliates of the issuer as of June 30 , 2020 ( the last business day of the registrant's most recently completed second fiscal quarter ) , was $ 278,374,634 . As of February 4 , 2021 , the number of shares outstanding of the registrant's Common Stock , $ 0.00005 par value per share , was 35,721,429 .